Salute e Benessere

Join Badael and Sign the Pledge for a Smoke-Free Saudi Arabia

In its first year, Badael achieved significant milestones, establishing and expanding its manufacturing capacity while investing substantially in research and development to enhance its product offering. The company has diversified its distribution channels, reaching a notable milestone of surpassing one million e-commerce orders since its inception – and helping around three hundred thousand people locally transition from tobacco. These achievements are a testament to Badael's commitment to…
PR Newswire
29/05/2024

FDA grants Priority Review to Roche's inavolisib for advanced hormone…

Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options 1,2 Additional analyses of INAVO120 will be presented in an oral abstract session at the 2024 American Society of Clinical Oncology Annual MeetingThe target action date for the FDA decision is 27 November, 2024Basel, 29 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has...
Nasdaq GlobeNewswire
29/05/2024

Information on the Total Number of Voting Rights and Shares

REGULATED INFORMATIONInformation on the Total Number of Voting Rights and SharesMont-Saint-Guibert (Belgium), May 28, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 5,851,253.43 Total number of securities carrying voting rights: 34,060,390 (all ordinary shares) ...
Nasdaq GlobeNewswire
28/05/2024

Cellectis Reports Financial Results for First Quarter 2024

• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca• Cash position of $143 million as of March 31, 2024 1 ; cash runway projection into 20262• Conference call and webcast scheduled for tomorrow, May 29, 2024 at 8:00AM ET / 2:00PM CET NEW YORK, May28, 2024(GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to...
Nasdaq GlobeNewswire
28/05/2024

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program…

New data from the completed dose escalation part and ongoing expansion part of Study 1100, an ongoing US Phase 1 study evaluating NBTXR3 followed by anti-PD-1 in patients with recurrent or metastatic head and neck cancer (n=68) to be presented by Coordinating Investigator Colette Shen, MD, PhD, at ASCO 2024Following the ASCO presentation, Nanobiotix will host an investor event on Sunday, June 2 ndat 12:00 PM EDT / 6:00 PM CEST to review the presented results PARIS and CAMBRIDGE, Mass...
Nasdaq GlobeNewswire
28/05/2024

Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young…

Among the more promising methods of tackling the issue is coming from the field of immunotherapies that help the body's immune system fight diseases, including cancer. One immunotherapy in particular that's gaining a lot of traction is pelareorep, the flagship asset of Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) — which gained its second FDA fast track designation 14 months ago. Among the more promising methods of tackling the issue is coming from the field of immunotherapies that help...
PR Newswire
28/05/2024

Groupe Casino: Completion of sale of Casino's stake in GreenYellow

Completion of sale of Casino's stake in GreenYellow Paris, 28 May 2024Casino Group confirms today the completion of the sale to Ardian and Bpifrance of its 10.15% residual stake in GreenYellow announced on 13 May 2024 ( link ) for net proceeds of EUR 46 million.Following this transaction, Casino Group no longer holds any stake in GreenYellow share capital. ***This press release has been prepared for information purposes only and should not be construed as a solicitation or offer...
Nasdaq GlobeNewswire
28/05/2024

Diabetic Kidney Disease Market Size to Worth USD 5.32 Bn By 2031

Market Dynamics: Market Dynamics : Rising geriatric population is one of the major drivers propelling the growth of the diabetic kidney disease market. As per estimates, by 2050 around 2 billion people globally will be aged 60 years and above. Elderly people are more prone to develop type 2 diabetes due to reduced immunity. Diabetes at an older age can further lead to kidney complications. Additionally, increasing incidence of obesity is also fueling the risk of diabetes, thereby augmenting...
PR Newswire
28/05/2024

Annual General Meeting of Ipsen S.A. held on 28 May 2024

All the resolutions submitted to the shareholders' vote have been adoptedPARIS, FRANCE, 28 May 2024 -The Annual General Meeting of Ipsen S.A. (Euronext: IPN; ADR: IPSEY) was held today at theSalons de l'Hôtel des Arts et Métiers, 9 bis, avenue d'Iéna, 75116 Paris (France), under the chairmanship of Mr. Marc de GARIDEL, Chairman of the Board of Directors, and in the presence of the members of the Board of Directors and the Group's Executive Leadership Team.The Annual General Meeting...
Nasdaq GlobeNewswire
28/05/2024

Concierge Medicine Market Size to Surpass USD 37.87 Bn By 2031

Market Dynamics: Market Dynamics : The concierge medicine market is driven by rising disposable incomes coupled with improving standards of living across the globe. As disposable incomes rise, people are able to afford better healthcare facilities such as concierge medicine. In addition, increasing burden of chronic diseases due to sedentary lifestyles and unhealthy diet is also fueling market growth. According to WHO, chronic diseases accounted for approximately 60% of all deaths...
PR Newswire
28/05/2024

SCENTAIR® BREAKS NEW GROUND WITH SUSTAINABLE FRAGRANCES & RECYCLABLE CARTRIDGES

The new line of Sustainable Fragrances is available across the business, accessible to both commercial clients globally and consumers in the United States. Businesses can improve customer experience while choosing a greener alternative by working directly with their ScentAir representative, while consumers can purchase the new eco-friendly fragrances directly from ScentAir's eCommerce store. The new line of Sustainable Fragrances is available across the business, accessible to both commercial...
PR Newswire
28/05/2024

Healthcare IT Market to be Worth $907.18 Billion by 2031 - Exclusive Report by…

Health information technology (HCIT) comprises various technologies that gather, store, analyze, and represent information for various areas in the healthcare sector. Over the years, the global healthcare IT industry has transitioned from the application of IT solutions from basic administrative functions to core clinical tasks. The increased amount of data gathered through patient records has now led to the deployment of advanced IT solutions in the healthcare sector. This includes the…
PR Newswire
28/05/2024

Stroke Diagnostics Market Size to Hit USD 5.32 Bn By 2031

Market Dynamics: Market Dynamics : The rising incidence of stroke around the world is a major factor driving the growth of the stroke diagnostics market. According to WHO, 15 million people suffer from stroke worldwide each year. Furthermore, advancements in diagnostic imaging technologies for stroke diagnosis are also boosting the market growth. Computed tomography (CT) scan and magnetic resonance imaging (MRI) have revolutionized stroke diagnosis by detecting occlusions and bleed with...
PR Newswire
28/05/2024

Tumor Ablation Market Worth $1.4 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142550258 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142550258 Browse in-depth TOC on "Tumor Ablation Market" 146 - Tables 56 - Figures 192 - Pages Tumor Ablation Market Scope: Microwave ablation segment to register significant growth rate over the forecast period of 2024-2029. Based on the technology, the global market is...
PR Newswire
28/05/2024

Global Smart Pills Market to Surge at a CAGR of ~11% by 2030 | DelveInsight

Key Takeaways from the Smart Pills Market Report Key Takeaways from the Smart Pills Market Report To read more about the latest highlights related to the smart pills market, get a snapshot of the key highlights entailed in theGlobal Smart Pills Market Report Smart Pills Overview Smart pills, also known as digital pills or ingestible sensors, represent a breakthrough in medical technology by combining pharmaceuticals with digital monitoring capabilities. These pills are...
PR Newswire
28/05/2024

BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and…

Bemcentinib is a first-in-class, selective, oral once-a-day inhibitor of AXL receptor tyrosine kinase, a promising therapeutic target for serious diseases. Pacritinib (marketed as VONJO®) is a JAK2 inhibitor indicated for treatment of myelofibrosis, a bone marrow disorder, and works by blocking certain growth factors and cytokines. Bemcentinib is a first-in-class, selective, oral once-a-day inhibitor of AXL receptor tyrosine kinase, a promising therapeutic target for serious diseases....
PR Newswire
28/05/2024

Metabolon Now Includes Spectral Data Files for All Global Discovery Panel…

"The availability of spectral data enhancement not only provides clients with a more comprehensive view of their metabolomics data but also reinforces our commitment to transparency and delivering unparalleled value to our clients," said Ro Hastie, CEO at Metabolon. "The availability of spectral data enhancement not only provides clients with a more comprehensive view of their metabolomics data but also reinforces our commitment to transparency and delivering unparalleled value to…
PR Newswire
28/05/2024

Calliditas Therapeutics Presents Data at the 61st European Renal Association…

Additionally, the findings of a real-world analysis of challenges associated with the use of systemic glucocorticoids demonstrate significant side effects and costs for IgAN patients treated with systemic glucocorticoids (SGC), such as Prednisone and Prednisolone. Additionally, the findings of a real-world analysis of challenges associated with the use of systemic glucocorticoids demonstrate significant side effects and costs for IgAN patients treated with systemic glucocorticoids (SGC), such...
PR Newswire
28/05/2024

Kinomica, King's College London and King's College Hospital NHS Foundation Trust…

Debashis Sarker MBChB FRCP PhD, Reader in Experimental Oncology, King's College London and Consultant Medical Oncologist at King's College Hospital, part of King's Health Partners, will present the results of the collaboration in a poster titled 'Identification of a predictive phosphoproteomic signature of response to atezolizumab and bevacizumab (AB) in patients with advanced hepatocellular carcinoma (aHCC)'. Debashis Sarker MBChB FRCP PhD, Reader in Experimental Oncology, King's College...
PR Newswire
28/05/2024

Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned…

J&J will gain full rights to develop, manufacture and commercialize NM26 globally for the treatment of atopic dermatitis and follow-on indications Under the agreement terms, J&J will pay $1.25 billion to acquire Yellow Jersey Therapeutics, which holds NM26 rightsNM26 is a Phase 2-ready bi-specific antibody from Numab's pipeline of candidates, discovered and engineered using its proprietary MATCH™ technology platform HORGEN, Switzerland, May28, 2024(GLOBE NEWSWIRE) -- ...
Nasdaq GlobeNewswire
28/05/2024

Oral Hygiene Product Market to Hit $36.4 Billion Valuation at 4.2% CAGR by 2034…

Food can get lodged in the mouth after each meal, leading to tooth decay and other issues. As a result, more individuals are using dental picks to remove food debris from between their teeth and flossing to eliminate food particles and plaque. Food can get lodged in the mouth after each meal, leading to tooth decay and other issues. As a result, more individuals are using dental picks to remove food debris from between their teeth and flossing to eliminate food particles and plaque. For...
PR Newswire
28/05/2024

Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to…

A New Frontier in Age-Related Therapies A New Frontier in Age-Related Therapies Products resulting from this collaboration will utilize Turn Bio's Epigenetic Reprogramming of Age (ERA TM ) technology and its novel eTurna™ delivery platform. These cutting-edge technologies aim to restore optimal gene expression, combatting the effects of aging at the cellular level to treat and potentially cure chronic conditions. "This partnership is a milestone for Turn Bio," said company CEOAnja...
PR Newswire
28/05/2024

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024Lausanne, Switzerland, May 28, 2023– AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering the development of precision medicine approaches for the diagnosis, treatment, and prevention of neurodegenerative diseases, today announced that Company Management will participate in a fireside chat and one-on-one investor meetings during the Jefferies 2024 Global Healthcare Conference,...
Nasdaq GlobeNewswire
28/05/2024

Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024

DUBLIN, May 28, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present three posters related to ALKS 2680 at SLEEP 2024, the 38th annual meeting of the Associated Professional Sleep Societies (APSS), taking place June 1-5, 2024 in Houston. ALKS 2680 is the company's novel, investigational, oral orexin 2 receptor (OX2R) agonist in development as a once-daily treatment for narcolepsy. DUBLIN,May 28, 2024/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today...
PR Newswire
28/05/2024
Altri  Comunicati